No evidence for differences in DNA damage assessed before and after a cancer diagnosis

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 4, 2008, Pages 990-994

  Bhatti, Parveen ^a   Sigurdson, Alice J ^a   Thomas, Cynthia B ^b   Iwan, Allison ^c   Alexander, Bruce H ^c   Kampa, Diane ^c   Bowen, Laura ^d   Doody, Michele Morin ^a   Jones, Irene M ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD SAMPLING; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER THERAPY; CLINICAL ARTICLE; COMET ASSAY; DISEASE ASSOCIATION; DNA DAMAGE; DNA REPAIR; ENDOMETRIUM CANCER; FEMALE; HUMAN; KIDNEY CANCER; LOGISTIC REGRESSION ANALYSIS; LYMPHOBLASTOID CELL LINE; MALE; MELANOMA; PRIORITY JOURNAL; SKIN CANCER;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COMET ASSAY; CONFIDENCE INTERVALS; DNA DAMAGE; FEMALE; HUMANS; MEDICAL RECORDS; MIDDLE AGED; NEOPLASMS;

EID: 42149177197     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2871     Document Type: Article

References (17)

1. Smith TR, Miller MS, Lohman KK, Case LD, Hu JJ. DNA damage and breast cancer risk. Carcinogenesis 2003;24:883-9.
2. Colleu-Durel S, Guitton N, Nourgalieva K, et al. Alkaline single-cell gel electrophoresis (comet assay): a simple technique to show genomic instability in sporadic breast cancer. Eur J Cancer 2004;40:445-51.
3. Schabath MB, Spitz MR, Grossman HB, et al. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst 2003;95:540-7.
4. Sigurdson AJ, Hauptmann M, Alexander BH, et al. DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals. Mutat Res 2005;586:173-88.
5. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-91.
6. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000;92:874-97.
7. Heikkilä K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Commun Health 2007;61:824-32.
8. Cheng L, Wang LE, Spitz MR, Wei Q. Cryopreserving whole blood for functional assays using viable lymphocytes in molecular epidemiology studies. Cancer Lett 2001;2:155-63.
9. Sigurdson AJ, Bhatti P, Doody MM, et al. Polymorphisms in apoptosis-related genes, ionizing radiation exposure, and risk of breast cancer among U.S. radiologic technologists. Cancer Epidemiol Biomarkers Prev 2007;16:2000-7.
10. Bhatti P, Struewing JP, Alexander BH, et al. Polymorphisms in DNA repair genes, ionizing radiation exposure, and risk of breast cancer among radiologic technologists. Int J Cancer 2008;122:177-82.
11. Sigurdson AJ, Doody MM, Rao RS, et al. Cancer Incidence in the United States Radiologic Technologists Health Study, 1984-1998. Cancer 2003;97:3080-9.
12. Lönn S, Bhatti P, Alexander BH, et al. Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of US radiologic technologists. Cancer Epidemiol Biomarkers Prev 2007;16:174-7.
13. Caporaso N. The molecular epidemiology of oxidative damage to DNA and cancer. J Natl Cancer Inst 2003;95:1263-5.
14. Collins A, Harrington V. Repair of oxidative damage: assessing its contribution to cancer prevention. Mutagenesis 2002;17:489-93.
15. Shaw GL, Galk RT, Deslauriers J, et al. Lung tumor resection does not affect debrisoquine metabolism. Cancer Epidemiol Biomarker Prev 1994;3:141-4.
16. Cloos J, Temmink O, Ceelen M, Snel MHJ, Leemans CR, Braakhuis BJM. Involvement of cell cycle control in bleomycin-induced mutagen sensitivity. Environ Mol Mutagen 2002;40:79-84.
17. Kennedy DO, Agrawal M, Shen J, et al. DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. J Natl Cancer Inst 2005;97:127-32.